Locations:
Search IconSearch

Cancer

Mobile mammograp
February 17, 2023/Cancer/Research

Researchers Aim to Improve Cancer Outcomes Among People Experiencing Homelessness

Early interventions, improved screening access and tailored support services can help patients navigate cancer care

Olivares, MD
February 13, 2023/Cancer

Minimally Invasive Focal Therapy Promising Approach for Select Patients with Prostate Cancer

A newer modality for select patients has shown positive outcomes to date

Novel Therapeutics Clinic
February 10, 2023/Cancer/Research

Novel Therapeutics Clinic Offers Access to Early-Phase Trials for Solid Tumors

Dedicated investigators and clinicians bring expertise in drug development and flexible study design

23-URL-3547358-CQD-650×450-1
February 9, 2023/Cancer

How Robotic-Assisted Surgery Is Improving Recovery Time in Patients with Metastatic Testicular Cancer (Podcast)

Why urologic oncologists favor the technique for select patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

endometrial cancer
February 8, 2023/Cancer/Research

Not All Stage 1 and 2 Endometrial Cancers are Alike

Retrospective study aims to better stratify risk of disease recurrence

TRAC clinic
February 7, 2023/Cancer/Patient Support

Taussig Rapid Access Clinic Reduces Emergency Room Visits for Patients with Cancer

Majority of 1,000 patients seen in 2022 discharged home

23-URL-3595064 CQD 650×450

National Prostate Cancer Trial Testing Therapy Based on Cleveland Clinic Molecular Discovery

Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer

22-CNR-3443384-CQD-Hero-650×450 Dr Lagman hospice care
January 31, 2023/Cancer/Research

Early Intervention Can Help Patients Benefit from Hospice Care at Home

Timely referral to hospice care reduces emergency room admissions

oral surgery
January 30, 2023/Cancer

New Research Investigates Salvage Surgery Outcomes in Oral Cavity and Oropharyngeal Cancers

The retrospective study identifies factors that influence disease-free and overall survival

lymphoma
January 27, 2023/Cancer/Research

Pembrolizumab Following Autologous Stem Cell Transplantation Shows Promise in T-Cell Non-Hodgkin’s Lymphoma

62% of patients were progression-free at 18 months post-transplantation

BackPage 22 of 112Next

Advertisement

Ad